Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study.

Foteinos-Ioannis D DimitrakopoulosGiannis MountziosPetros ChristopoulosThomas PapastergiouMariam ElshiatyLea DanielloElefterios ZervasSofia AgelakiEpaminondas SamantasAdamantia NikolaidiIlias AthanasiadisSofia BakaKonstantinos SyrigosAthina ChristopoulouEvangelos LianosKonstantinos SamitasNikolaos TsoukalasEleni-Isidora PerdikouriGeorge OikonomopoulosAnastasia KottorouFoteini KalofonouThomas MakatsorisAngelos KoutrasVasileios MegalooikonomouHaralabos Kalofonos

Published in: Therapeutic advances in medical oncology (2022)

This study provides further validation of PIOS in aNSCLC patients treated with anti-PD-1 monotherapy.

Keyphrases

advanced non small cell lung cancer
small cell lung cancer
clinical trial
open label
randomized controlled trial
newly diagnosed
epidermal growth factor receptor